Table 2 Incidence of LH rises (≥10 IU/L) and of LH rises with P rises (≥3.18 nmol/L) measured at stimulation day 5 or 6 prior to the start of ganirelix treatment and during ganirelix treatment
Ganirelix start day | % (95% CI), n/N | P value* | ||
|---|---|---|---|---|
LH rises | Early | Day 5 | 2.3 (1.4-3.4) | < 0.01 |
22/955 | ||||
Day 6 | 6.6 (5.2-8.2) | |||
74/1113 | ||||
Late | Day 5 | 1.2 (0.6-2.0) | 0.06 | |
11/949 | ||||
Day 6 | 2.3 (1.4-3.3) | |||
25/1096 | ||||
LH+P rises | Early | Day 5 | 1.0 (0.5-1.9) | 0.11 |
10/955 | ||||
Day 6 | 2.0 (1.2-2.9) | |||
22/1113 | ||||
Late | Day 5 | 0.5 (0.2-1.2) | 0.44 | |
5/949 | ||||
Day 6 | 0.9 (0.4-1.6) | |||
10/1096 | ||||